Detalhe da pesquisa
1.
COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice.
J Virol
; 95(7)2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33414159
2.
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
J Virol
; 92(11)2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29514907
3.
Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice.
NPJ Vaccines
; 7(1): 17, 2022 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35140227
4.
MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters.
Front Immunol
; 13: 845969, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35371064
5.
Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2.
Front Immunol
; 13: 845887, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35371043
6.
A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection.
Front Immunol
; 12: 824728, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35154086
7.
The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses.
Emerg Microbes Infect
; 10(1): 1441-1456, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34213405
8.
Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B.
Vaccines (Basel)
; 8(1)2020 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32041218
9.
An MVA Vector Expressing HIV-1 Envelope under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design.
Vaccines (Basel)
; 7(4)2019 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31817622
10.
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice.
Sci Rep
; 8(1): 17385, 2018 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478418